GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (NAS:QDEL) » Definitions » Shiller PE Ratio

QuidelOrtho (QuidelOrtho) Shiller PE Ratio : 7.15 (As of Apr. 29, 2024)


View and export this data going back to 1992. Start your Free Trial

What is QuidelOrtho Shiller PE Ratio?

As of today (2024-04-29), QuidelOrtho's current share price is $40.33. QuidelOrtho's E10 for the quarter that ended in Dec. 2023 was $5.64. QuidelOrtho's Shiller PE Ratio for today is 7.15.

The historical rank and industry rank for QuidelOrtho's Shiller PE Ratio or its related term are showing as below:

QDEL' s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.94   Med: 88.18   Max: 597.3
Current: 7.15

During the past years, QuidelOrtho's highest Shiller PE Ratio was 597.30. The lowest was 6.94. And the median was 88.18.

QDEL's Shiller PE Ratio is ranked better than
93.12% of 276 companies
in the Medical Devices & Instruments industry
Industry Median: 26.93 vs QDEL: 7.15

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

QuidelOrtho's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.100. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $5.64 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


QuidelOrtho Shiller PE Ratio Historical Data

The historical data trend for QuidelOrtho's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuidelOrtho Shiller PE Ratio Chart

QuidelOrtho Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 279.00 82.32 33.89 15.58 13.07

QuidelOrtho Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.58 15.86 14.78 12.92 13.07

Competitive Comparison of QuidelOrtho's Shiller PE Ratio

For the Medical Devices subindustry, QuidelOrtho's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Shiller PE Ratio falls into.



QuidelOrtho Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

QuidelOrtho's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=40.33/5.64
=7.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuidelOrtho's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, QuidelOrtho's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.1/129.4194*129.4194
=0.100

Current CPI (Dec. 2023) = 129.4194.

QuidelOrtho Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.040 99.695 -0.052
201406 -0.200 100.560 -0.257
201409 -0.170 100.428 -0.219
201412 0.200 99.070 0.261
201503 0.110 99.621 0.143
201506 -0.260 100.684 -0.334
201509 -0.020 100.392 -0.026
201512 -0.010 99.792 -0.013
201603 -0.110 100.470 -0.142
201606 -0.240 101.688 -0.305
201609 -0.020 101.861 -0.025
201612 -0.060 101.863 -0.076
201703 0.420 102.862 0.528
201706 -0.350 103.349 -0.438
201709 -0.160 104.136 -0.199
201712 -0.150 104.011 -0.187
201803 0.860 105.290 1.057
201806 -0.080 106.317 -0.097
201809 0.270 106.507 0.328
201812 0.780 105.998 0.952
201903 0.600 107.251 0.724
201906 0.030 108.070 0.036
201909 0.380 108.329 0.454
201912 0.710 108.420 0.848
202003 0.930 108.902 1.105
202006 1.550 108.767 1.844
202009 5.330 109.815 6.282
202012 10.780 109.897 12.695
202103 4.090 111.754 4.737
202106 0.450 114.631 0.508
202109 5.080 115.734 5.681
202112 6.850 117.630 7.537
202203 11.310 121.301 12.067
202206 0.360 125.017 0.373
202209 0.280 125.227 0.289
202212 0.450 125.222 0.465
202303 0.730 127.348 0.742
202306 -0.800 128.729 -0.804
202309 -0.190 129.860 -0.189
202312 0.100 129.419 0.100

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


QuidelOrtho  (NAS:QDEL) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


QuidelOrtho Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


QuidelOrtho (QuidelOrtho) Business Description

Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Executives
Louise Brandy officer: SVP, Chief Information Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Patrick Klein officer: Chief Administrative Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Christopher M Smith director 125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Edward L. Michael director 618 SHERIDAN SQUARE, EVANSTON IL 60202
William J. Ferenczy officer: SVP, Cardio/Metabolic Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Werner Kroll officer: SVP, Research and Development 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Kenneth F Buechler director
Robert R. Schmidt director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tamara A. Ranalli officer: SVP, Molecular Bus. Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Stephen H. Wise director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Robert Joseph Bujarski officer: See Remarks C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Wilkins Joseph D Jr. director 82414 PUCCINI DRIVE, INDIO CA 92203
Michelle A. Hodges officer: SVP, General Counsel 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Douglas C Bryant director, officer: Chairman & CEO C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Joseph M Busky officer: Chief Financial Officer 1717 DEERFIELD ROAD, DEERFIELD IL 60015